What is Veracyte's capex?

Veracyte (VCYT) reported capex of $2.96M in Q1 2026.

How has Veracyte's capex changed year-over-year?

Veracyte's capex increased by 62.8% year-over-year, from $1.82M to $2.96M.

What is the long-term trend for Veracyte's capex?

Over 4 years (2021 to 2025), Veracyte's capex has grown at a 15.8% compound annual growth rate (CAGR), from $5.38M to $9.68M.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Veracyte VCYT CapEx

CapEx at other companies

Guardant HealthGH

$5.58M+25.1%

Natera, Inc.NTRA

$22.14M+1.5%

Bio-Rad LaboratoriesBIO

$30M-12.8%

RevvityRVTY

$19.78M+23.7%

Labcorp HoldingsLH

$121M-4.0%

Quest DiagnosticsDGX

$114M-2.6%

Other financials

Income statement

See full

Revenue$139.1M+21.5%

Gross profit$101.2M+27.2%

Operating income$22.6M+680%

Net income$28.7M+307%

EPS (diluted)$0.35+289%

Balance sheet

See full

Cash & equivalents$264.8M+41.0%

Total debt$39.3M-22.1%

Total equity$1.3B+12.5%

Total assets$1.4B+9.2%

Cash flow

See full

Operating cash flow$35.2M+557%

Free cash flow$32.3M+810%

Valuation

See full

Market cap$4.28B+10.7%

Enterprise value$4.05B+7.4%

P/E48.6×-68.3×

P/S7.9×-0.4×

Profitability

See full

Gross margin70.9%+2.9pp

Operating margin14.3%+9.2pp

Net margin16.2%+9.1pp

FCF margin28.7%+11.7pp

Returns & leverage

See full

Return on equity6.9%+4.1pp

Debt / equity0×0.0×

Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Veracyte's capex?: Veracyte (VCYT) reported capex of $2.96M in Q1 2026.
How has Veracyte's capex changed year-over-year?: Veracyte's capex increased by 62.8% year-over-year, from $1.82M to $2.96M.
What is the long-term trend for Veracyte's capex?: Over 4 years (2021 to 2025), Veracyte's capex has grown at a 15.8% compound annual growth rate (CAGR), from $5.38M to $9.68M.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.